Discussion Topic: Arrhythmic Prognosis According to Left Ventricular Systolic Dysfunction Severity in Cardiac Sarcoidosis
William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Edoardo Bressi, MD Queen Elizabeth Hospital – University Hospitals Birmingham, and Jordana Kron, MD Virginia Commonwealth University to discuss the current guidelines that present varying classes of recommendations for implantable cardioverter-defibrillator (ICD) utilization in patients with cardiac sarcoidosis (CS) and left ventricular ejection fraction (LVEF) <50%. This podcast episode explores a manuscript describing outcomes in these patients.
Host:Â William H. Sauer, MD, FHRS, CCDS
Guests:Â Jordana Kron, MD and Edoardo Bressi, MD
Speaker and Article Information:Â Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 149: Heart Rhythm 2026 Late-Breaker Coverage: A Discussion of Safety and Performance of a Novel ICD Lead for Left Bundle Branch Area Pacing: Results from the ASCEND CSP Trial
May 14, 2026
The Lead
Podcasts
The Lead Episode 150: Heart Rhythm 2026 Late-Breaker Coverage: A Discussion of Total Fatal Adverse Events Following Atrial Fibrillation Ablation Reported in an FDA Mandatory Reporting System: A Matter of Concern? The TiFFANY Study
May 14, 2026
The Lead
Podcasts
The Lead Episode 148: The Lead Episode 148: HRS 2026 Late-Breaker Coverage, A Discussion of Ventricular Intramyocardial Navigation and Tachycardia Ablation Guided by Electrograms (VINTAGE): First-in-Human Experience with a Novel Therapy for Refractory Ventricular Arrhythmias
May 14, 2026